Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Prescott Valley. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Prescott Valley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study compares the efficacy of adagrasib in combination with pembrolizumab versus pembrolizumab in patients with unresectable, locally advanced or metastatic squamous or nonsquamous NSCLC with KRAS G12C mutati
Sponsor: Mirati Therapeutics Inc.
Check if you qualify for this non-small cell lung cancer clinical trial in Prescott Valley, AZ
If you're searching for non-small cell lung cancer treatment options in Prescott Valley, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Prescott Valley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.